Background: Covid-19 is responsible for high rates of mortality worldwide. Comorbidities such as hypertension (HAS), diabetes mellitus (DM), and obesity are listed as possible causes of the severe form of this disease. Therefore, it was hypothesized an increased prevalence of metabolic syndrome (MS) in Covid-19 patients after hospital discharge. Aim: Evaluate the prevalence of MS among patients who needed hospitalization. Methods: Transversal, retrospective study conducted in a multidisciplinary Long-Covid outpatient centre. The first evaluation was performed after 60 days of discharge, all covid-19 survivors were invited to be followed at the outpatient clinic. Adults of both sexes with clinical assessment and laboratory data for MS diagnosis according to NCEP-ATP III were included. Results: 133 discharged patients were included, mean age 59.4± 14.6 years, 47% male, and median of hospitalization was 15 (10-24) days. 44% was hospitalized in the intensive care unit and 22% need mechanical ventilation. Among comorbidities, we identified 62.4% of obesity, 52% hypertension, 40% type 2 DM, and 44.3% dyslipidaemia. The prevalence of MS in the ward hospitalized patients was higher (47%) when compared to patients who needed mechanical ventilation (10%) (p=0.002). We did not observe statistical differences between groups of type of hospitalization in the ICU or ward proportion of MS (43.6%x38%) as well as the proportion of DM (49%x38%), HAS (54%x58%) and obesity (65%x55%). Conclusion: There was a high prevalence of MS in these survival patients after covid-19 infection and can increase further cardiovascular diseases.